Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_101_библиотеки_им_акад_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
52 Мб
Скачать
https://t.me/med1917
198
Upstream Processing
particles. Choosing a lower ow rate can provide sufcient time for smaller particles to settle before leaving the rotor or bowl, and optimizing ow rate can enhance process efciency.
• Cell density, viability, and cell type are other variables to consider when choosing centrifuga­tion as a separation choice. The solid to liquid ratio will determine how soon the pellets (solid’s settling) accumulate and ll the bowl leading to a possibility of packing up into the claried stream. As such, the pellet may need to be intermittently or continuously removed. Turbidity measurements of the supernatant/ claried liquid can be useful in such scenarios, which will increase as the bowl reaches its holding capacity. A balance is critical to minimize loss.
Assessing these variables on scale- down models can be challenging due to the limited avail­ability of suitable representative models for continuous ow centrifuges. Benchtop or conventional centrifuges cannot replicate the dynamics of a continuous centrifuge.
10.6.2 dePth filtRation
Unlike surface or membrane ltration, depth ltration employs the depth of the ltering medium and its absorptive properties (porous substrate) to retain particles from the feed stream. The structure of depth lters consists of multiple layers or even a single thick layer of culture media. Larger particles are captured at the surface, while smaller or ner particles are entrapped within the various layers or structures. Depth lters are not identied to have a dened pore structure like other lters do. In a membrane lter, particles larger than the pore size are trapped on the membrane’s surface. Thus, the depth lter leverages the depth of the membrane media and surface- based sieving for applications such as cell culture harvest and intermediates (e.g., precipitated solutions, refolded protein pro­cessing before chromatography steps; Figure 10.8).
FIGURE 10.8 Comparison of membrane and depth lter functionality
https://t.me/med1917
Upstream Processing
199
Depth lters are constructed using cellulose or polypropylene bers combined with lter aids like diatomaceous earth (DE) or perlite. These bers are bound together with a polymeric resin using the wet- laid process, forming the matrix of the lters. The ber matrix provides rigidity and structure, while lter aids increase surface area to enhance retention properties. Additionally, the resin imparts wet strength and a positive charge to the lter surface. Some lters may incorporate an additional lter membrane layer with different pore sizes (e.g., 0.2 μm). When selecting a suitable depth ltration system for primary or secondary clarication of the feed, consider variables such as lter selection, format, and surface area. The choice of depth ltration for cell culture applications depends on culture conditions and the physical properties of the product, particularly if it involves proteins present in the feed for mammalian cultures.
Depth ltration offers several advantages, including ease of implementation, single- use cap­ability, faster turnaround times, reduced or no cleaning requirements, scalability, and low invest­ment. In single- use systems, lter units can be stacked together to increase surface area, allowing for easy scaling to handle large volumes (greater than 5,000 L of harvest). These lter units, or capsules, consist of lter culture media, along with inlet and outlet single- use manifolds equipped with vents positioned between lters. These capsules are arranged into stainless steel holders, although the stainless steel parts do not come into contact with the product. Commercially avail­able single- use systems, such as 3M Encapsulated Zeta Plus and Millistak+ Pod lter systems by Millipore, are widely used in various industries. Depth lters are well- suited for a range of clarica­tion applications, including cell culture, yeast, E. coli lysates (after centrifugation), refolded proteins (after E. coli IB solubilization), vaccines, and plasma proteins.
The setup for depth ltration is straightforward (Figure 10.9). Before starting the harvest pro­cess, it’s essential to ush the depth lters with water or a recommended buffer to remove any loose particulates and extractives that may have been trapped during the manufacturing process. Subsequently, the unclaried culture is introduced into the lter setup through the inlet. A pump is then used to drive the feed from the outside, passing through the lter culture media and traveling through its depth to achieve clarication. After completing the harvest process, the lter culture media is once again ushed with water buffer to recover the unit’s volume and minimize product loss.
The void volume of depth lters varies depending on pore structures, with more open pore structures having a high void volume (around 90 percent) and tighter pore structures having lower void volumes (around 30– 40 percent). To ensure successful clarity, it is crucial to select the appro­priate lter grade based on the particle size distribution. In many cases, multiple lter grades are arranged in series to improve overall clarication performance. Following clarication, the harvested material is ltered through a 0.2 μm lter. Single- use bags are advantageous in this application for easy storage and maintaining sterility until further processing. Properly sizing the depth ltration process is essential for tight process control, preventing batch losses, or processing delays. Depth ltration also offers benets in reducing shear stress, limiting cell damage, and removing impurities such as HCP, DNA, and endotoxins, compared to centrifugation.
10.6.3 ultRafiltRation and MicRofiltRation tangential floW filtRation
Membrane ltration techniques, such as ultraltration and microltration, can be effectively used in the recovery and separation process post- fermentation. Hollow ber lters have enabled
FIGURE 10.9 Schematic of a depth ltration setup (primary or secondary clarication)
https://t.me/med1917
200
Upstream Processing
the application of ultraltration and microltration TFF (tangential ow ltration) in large- scale operations, including clarication and cell retention in perfusion processes. The choice between microltration and ultraltration depends on membrane pore size, with microltration typically having pores around 0.1 μm and ultraltration membranes having even smaller pores categorized by molecular weight cutoff. While microltration and ultraltration are commonly used in downstream processing, recent advances have positioned these methods as suitable alternatives to traditional centrifugation. TFF is successful in cell harvest and cell lysate processing, relying on size exclusion for ltering separation and utilizing crossow to remove cells and detritus from the membrane’s sur­face. The retentate pool containing cells is concentrated while the cell culture is treated. A frequently encountered issue with this system is lter fouling, which drops the performance and recovery. This can be overcome by incorporating dialtration or cell washing, which is benecial for buffer exchange in chromatography applications and cell lysis.
The selection of the appropriate membrane pore size is crucial for process efciency. Hence, identifying the membrane with the appropriate pore size is key to developing an effective clarica­tion or cell harvesting process. Smaller pore size membranes provide higher permeate ux under steady- state conditions, so choosing a larger pore size ultraltration membrane for E. coli, even with relatively small pores compared to the cells, may be advantageous. For applications where proteins are secreted in the medium, open pore size microltration membranes in the range of 0.2 to 0.65 μm are preferred, especially for larger recombinant proteins like monoclonal antibodies. Selecting a membrane pore size at least ten times larger than the target material ensures proper passage through the membrane.
In the case of hollow ber lters, the cartridge’s length and the inner diameter of the bers inuence the process. Shorter path lengths are suitable for processing cultures. Other variables affecting the clarication process include permeate ow rate, recirculation ow rate, and timing of dialtration (cell washing) to facilitate particle passage (cells or proteins).
10.6.3.1 Choosing the Appropriate Method
The primary goals for clarication include
• consistent removal or separation of cells,
• removal of insoluble debris,
• reproducibility and scalability
In addition to these goals, increasing throughput to reduce processing time, minimize product degradation, product loss, and downstream operation burden are essential considerations when selecting a clarication method.
The choice of clarication method should be based on the cell type. E. coli is primarily used for producing simple proteins and antibody fragments that do not require glycosylation. Most bacterial expression systems involve a centrifugation step to recover the pellet from which the protein is puri­ed. Subsequently, cell lysis is performed to release the recombinant protein. During the cell lysis and inclusion body (IB) recovery process steps, alternatives to centrifugation such as microltration and ultraltration, can be considered for processing cell lysates and recovering IBs. For refolded proteins, particularly on an industrial scale, depth ltration is often the preferred choice of clari­cation. Microltration membranes can concentrate cells and disrupt them using a homogenizer to separate the inclusion bodies. Cell debris and IBs can be separated using either microltration membranes (0.2 µm) or ultraltration membranes.
Harvesting methods for E. coli secreting soluble proteins are similar to those used in mammalian production systems, such as centrifugation, depth ltration, and sterile ltration. While process modications may be necessary to accommodate the more intensive fermentation characteristics of E. coli cultures, like high cell density and short cell culture time, similar process equipment and
https://t.me/med1917
Upstream Processing
FIGURE 10.10 Alternate ltration system for processing E. coli products
201
optimization strategies should be expected. In processes where cells are engineered (e.g., using secretion tags and other changes to the E. coli construct) to release the product from the periplasm or into the extracellular space, it’s crucial to avoid shear stress on the cells. Precipitation and occu­lation (e.g., with polyionic polymers like PEI and dextran) in conjunction with centrifugation can assist in rapid processing, stabilizing the product, and efciently removing cell debris, colloidal proteins, and nucleic acids.
CHO cells are another common expression system. In most mammalian systems, proteins are secreted from these cells into the culture medium. Therefore, the clarifying process involves removing cells and soluble debris. Centrifugation, depth ltration, or tangential ow microltration are commonly used for primary clarication. To eliminate smaller particles and protect the chro­matography column, a nal ltration step is included. For this purpose, a 0.2 µm rated sterilizing grade lter is used. To preserve the more sensitive sterilizing grade lter layer, a dual- layer sterile lter, such as a 0.45 µm over a 0.2 µm lter, is commercially employed. Recent techniques, such as intensication and cell engineering, have led to higher cell densities, necessitating improved impurity removal to facilitate downstream operations. The clarication process is critical to min­imize particle content (cells, debris, impurities like DNA, endotoxin, HCP) in the load for the subse­quent chromatography step (e.g., Protein A) and reduce fouling of the stationary phase.
The solid content per unit volume, often referred to as cell density and viability, plays a crucial role in determining the choice of clarication method, performance efciency (yield), and overall effectiveness. High cell density can lead to increased levels of DNA, HCP, and other cell debris. Centrifugation is effective for handling high cell concentrations and processing large volumes, rendering depth ltration or microltration less effective at such high cell densities. However, cen­trifugation can have drawbacks due to the shear stress it imparts on cells, increasing the risk of cell lysis and impurities. To address this concern, occulation or precipitation techniques may be employed. Figure 10.10 illustrates the available options for establishing a robust harvest system tailored to the specic cell line and target protein.
The modernization of existing harvesting methods to accommodate high cell density, increased biomass, and improved impurity removal can signicantly enhance the purication process. Therefore, it may be benecial to explore additional techniques and strategies, if necessary, to achieve the highest level of clarication efciency.
10.7 ANALYTICAL TOOLS
Qualitative and quantitative analytical tools play a pivotal role in validating the process across various scales. Analytical methods must be precise, accurate, and robust. The data obtained from these analyses inform decision- making throughout the entire process, from early- stage cell line development to the nal product. In- process testing is a crucial component in enabling Process
https://t.me/med1917
202
Upstream Processing
Analytical Technologies (PAT), which involves understanding process parameters, conditions, and materials to develop an effective control strategy. According to the ICH Q10 guideline, a control strategy is dened as “a planned collection of controls derived from current product and process understanding that guarantees process efciency and product quality.” Here, we summarize some of the critical upstream analytical tools frequently used.
10.7.1 cell cultuRe/ feRMentation
Growth monitoring is the primary analysis in the culture process, determining whether the existing conditions favor cell growth. Various ofine methods are available for monitoring bacterial cells, with spectrophotometry being the most widely used due to its simplicity, speed, and reliability. Microscope counting is an alternative, albeit cumbersome and less reliable method. For mammalian cell cultures, the trypan blue method (using a microscope and hemocytometer) is common. Several automated cell- counter instruments, such as the Vicell Cell Viability Analyzer and Cedex Cell Analyzer, offer pre- programmed and customizable solutions, estimate cell sizes, and handle various animal cells.
While these methods remain popular for cell density measurements, recent years have seen the emergence of online cell density measurements, similar to the monitoring of pH and dissolved oxygen (DO). Microuidic mass sensors and in- situ sensors now allow for continuous measurements. For example, the Incyte Arc sensors by Hamilton utilize capacitance to measure the polarization of viable cells. Another example is the Dencytee Total cell density sensors, also by Hamilton, which rely on optical density or turbidity measurements at near- infrared (NIR) wavelengths.
Measurement of parameters such as pH, pCO2, osmolality, and various metabolites (e.g., glucose, lactate, glutamine, sodium, potassium) is typically carried out using ofine blood gas analyzers such as the YSI analyzer and NOVA Biochemical Analyzer.
Productivity estimation is commonly performed through periodic sampling during the fermentation process. Common quantitation methods include ELISA, Protein A HPLC, and protein biosensor systems (e.g., ForteBio Octet). AlphaLISA, a high- throughput immunoassay with high sensitivity, reduces testing time and eliminates some steps involved in traditional ELISA. In the case of bacterial cells, SDS- PAGE is the most frequently used method for culture analysis and inclusion body (IB) separation.
Glycosylation patterns depend signicantly on cell culture conditions and media/ feed compos­ition, which can have a substantial impact on downstream purication strategies. Glycan mapping using the UHPLC method is commonly employed for analyzing glycan proles (O- linked and N­linked). Additionally, high- resolution mass spectrometry aids in determining glycosylation patterns and degrees (glycoprotein proling). While several orthogonal methods are used for glycan analysis of the drug substance (Critical Quality Attributes testing), these methods may not be necessary in the early stages of the manufacturing process.
Both ofine and in- line product monitoring offer several advantages, including the identication of optimal feeding strategies and culture conditions that can enhance product quality and potentially reduce the need for additional testing until the nal drug substance preparation (e.g., glycan analysis).
10.7.2 cell haRvest
Turbidity serves as a valuable tool for assessing clarication efciency. It measures the extent of light scattering when passed through a sample containing suspended particles. This measurement is expressed as Nephelometric Turbidity Units (NTUs), with lower NTU values indicating better clari­cation. This method is used to effectively compare different clarication techniques.
The step yield is determined based on the amount of product recovered at the end of the harvest process. Additionally, for certain processes, estimating the levels of HCP and DNA, predominantly achieved in downstream purication processes, can offer valuable insights into the achieved level of purication.
https://t.me/med1917
Upstream Processing
10.8 UPSTREAM EQUIPMENT
203
The technology for upstream unit processes has evolved signicantly over the past few decades. Originally developed for fermentation, these systems now enable the growth of various cell cultures capable of yielding a target protein molecule. The biological process of cell growth and expres­sion becomes more sensitive when genetically modied organisms are involved. To address these challenges, bioreactors are now designed with advanced technology to ensure reproducible batch yields. This chapter provides an overview of the equipment and operational processes that play a central role in biopharmaceutical production. While the science of bioprocessing involves a deeper understanding of the physics and chemistry of bioprocesses, this chapter focuses on the equipment commonly used in commercial settings.
One of the key criteria for biomanufacturing processes is creating an optimal environment for all unit operations that support cell growth, isolation/ clarication, and purication to produce the desired product. Consequently, the facility and equipment are critical components in dening the process, its performance, and its robustness.
Upstream processing includes cell growth, cell isolation, and harvest, which require equipment and systems such as:
• Media and Solution Prep Systems.
• Bioreactor Systems for Fermentation.
• Harvest and Clarication Systems.
In addition to the above, other peripheral sanitary equipment essential for the entire bioproduction process (upstream, downstream, and ll- nish) includes Clean- in- Place (CIP) systems, sterilization systems, decontamination, biowaste systems, and various disposable/ single­use systems.
10.9 MEDIA AND SOLUTION PREPARATION SYSTEMS
Vessels and tanks are primarily used for blending, holding bulk liquid volumes, and transport. At the end of the bioreaction, these vessels are used to introduce materials (media, feed, and other solutions) into the bioreactor and transfer either parts or the entire reactor volume to the next unit operation. Stainless steel alloys (particularly 304 and 316) are the most commonly used construc­tion materials for large tanks, but single- use systems are now widely adopted across a broad volume range. These single- use systems are discussed in more detail in Chapter 9.
These vessels can range from simple storage containers to vessels equipped with overhead mixers. Features like temperature control, load cells, pH control, liquid/ solid additions, withdrawal, and gassing can determine the specic use of these tanks or vessels. Jacketed vessels are commonly used for temperature control, especially in large- scale preparations, where a temperature control uid circulates inside the jacket to maintain the required temperature in the process uid. Other tem­perature control components that may be used include an immersion heat exchanger and a heating blanket.
For vessels with built- in load cells, all additions are based on weight, eliminating the need to move large tanks for weighing. In large- scale preparations, weight- based solution preparation is more benecial than volume- based. For lling and transfer, the process length can be established by setting the overall lling time or dening a lling rate (e.g., kg/ min) for a vessel with a known volume. pH measurements in bioprocess liquid preparations are typically done ofine through manual sampling from the preparation tank. However, in high- end systems, such as bioreactor vessels, continuous online monitoring with a pH probe may be used for pH measurements and adjustments.
https://t.me/med1917
204
10.10 BIOREACTOR SYSTEMS
Upstream Processing
A bioreactor is a sealed vessel used to support biological systems (e.g., bacterial cells, yeast, mam­malian cells) for the production of biopharmaceuticals (such as vaccines and antibodies), primary and secondary metabolites (including ethanol and biofuel), and even in tissue engineering. The rst bioreactor was developed in 1857 by Louis Pasteur to study the fundamental principles of fermen­tation. This milestone in bioprocessing, along with advancements in cell biology and recombinant DNA technology, paved the way for further developments in bioreactor design and their industrial applications beyond food products.
Bioreactor design relies on several factors, including cell type, product throughput, quality control, and mass transfer. The duration required for processes is critical to bioreactor design and establishing operational parameters. The material used for the bioreactor vessel should endure repeated sterilization cycles without affecting long- term performance or durability. The preferred materials are glass (for small- scale benchtop bioreactors) or stainless steel, with 316 SS for wetted parts and 316L SS for animal cell cultures. Non- product contact surfaces can be made of 304- type stainless steel. For microbial cultures, a height- to- diameter ratio of 2:1 or 3:1 is preferred for high gas transfer, while a ratio of 1:1 is common for animal cell cultures. Bioinstrumentation and process control features to ensure sterility are essential design characteristics for bioreactors. Key func­tionalities include maintaining sterility, providing aeration (oxygen), removing gaseous products (carbon dioxide), controlling and optimizing the environment for cell growth (e.g., temperature con­trol, pH, agitation), minimizing evaporation losses, and enhancing process efciency.
10.11 BIOREACTOR TYPES
10.11.1 stiRRed tanK bioReactoR
In bioprocesses, the stirred tank reactor (STR) is the most common and widely used bioreactor type. They vary in complexity from simple stirred tanks for enzymatic reactions to more advanced aerated fermenters for metabolic bioconversions. A compressor introduces air from the bottom through sub- surface spargers to provide necessary aeration. Agitation via an impeller shaft (equipped with bafes) facilitates mixing and dispersing air bubbles within the vessel’s contents, which are crucial for bioreactor performance. Stirred tank reactors are highly adaptable, with high kLa (volumetric mass transfer coefcient) values for gas transfer. Jacketing is often used for heating and cooling. The height- to- diameter ratio depends on the intended use, ranging from 1 for basic vessels with limited surface area per unit volume to 3 for large- scale reactors. This type of reactor operates in one of these modes: batch, fed- batch, or continuous. Various operation modes are explained below (Figures 10.11 and 10.12).
10.11.2 aiRlift bioReactoR
An airlift or gas- lift bioreactor is a gas- liquid bioreactor that achieves agitation without mechanical devices, relying on sparged air’s convection. A glass grid aerator aids in humidied air dispersion, promoting mixing and oxygenation while using less energy than a stirred tank reactor. Only a spe­cic area of the vessel, called the riser, is sparged with gas. Gas holdup and volumetric mass transfer coefcient (kLa) are inuenced by operating conditions. The medium moves upward in the riser due to gas holdup and reduced uid density. At the top of the reactor, bubbles disengage, and the denser medium ows downward into the downcomer, a non- sparged section of the pipe. Oxygen transfer is often lower than in stirred tank bioreactors due to low shear levels. Airlift bioreactors nd extensive use in plant and animal cell growth, as well as immobilized biocatalysts.
However, they tend to form dead zones due to non- uniform nutrient distribution and inadequate mixing (Figure 10.13).
https://t.me/med1917
Upstream Processing
205
FIGURE 10.11 Stirred bioreactor
Source: Yassine Mrabet– Own work, CC BY- SA 3.0, https:// comm ons.wikime dia.org/ w/ index.php?curid= 8301 774
FIGURE 10.12 Schematic of an airlift bioreactor. (a) bubble column reactor (BCR), and (b) internal- loop airlift reactor (ALR)
Source: https:// www.mdpi.com/ 2227- 9717/ 8/ 6/ 713/ htm; http:// crea tive comm ons.org/ licen ses/ by/ 4.0/
https://t.me/med1917
206
Upstream Processing
FIGURE 10.13 Fluidized bed bioreactor
Source: YassineMrabet– Own work based on Fluidized Bed Reactor Graphic. JPG (user: Hughesy127), Public Domain, https:// comm ons.wikime dia.org/ w/ index.php?curid= 8278 465
10.11.3 PacKed bed and fluidized bed bioReactoR
The chemical industry employs packed bed reactors for various processes, such as distilla­tion, absorption, separation, and catalytic reactions. In a packed- bed bioreactor, immobilized biocatalyst particles (enzyme or microbial cells) ll a tube- shaped vessel. The liquid medium ows either uphill or downhill through the column, interacting with the catalyst spread along its length. Rapid liquid phase velocity enhances mass transfer. To improve catalyst conversion, the process medium is typically recycled through the column multiple times, often requiring an inter­mediate storage tank. Fluidized beds are a type of packed bed reactor where the liquid medium ows upwards, allowing the bed to expand at high ow rates, known as extended– or uidized- bed bioreactors. Biocatalyst particles must have suitable size and density. Continuous movement of particles prevents channeling and clogging. However, understanding mass and energy transfers and accounting for potential pressure drops along the reactor’s length are critical challenges in packed bed reactor design.
Different types of bioreactors include the loop reactor, immobilized cell reactor, solid- phase tray reactor, rotary drum reactor, agitated tank reactor with a movable impeller, hollow ber reactor, and the widely popular disposable WAVE™ bioreactor (Figure 10.14).
Several iterations of the Wave bioreactors have been reported in recent patents by Niazi (author of this book), including a bafed bioreactor (Figures 10.15 and 10.16).
r
Xm XSo/tcYX SM
tc
https://t.me/med1917
Upstream Processing
207
FIGURE 10.14 Schematic of a rocking bioreactor
10.12 MODES OF OPERATION
There are four modes of operation available for bioreactors: batch, fed- batch, perfusion, and con­tinuous fermentation.
In the early days of biopharma manufacturing, the batch mode was predominantly used due to its simplicity. However, over time, fed- batch has become more prominent for microbial and animal cell culture, offering increased productivity compared to the traditional batch mode. Perfusion, ori­ginally considered precise, has also gained renewed interest, especially for animal culture, as an alternative to fed- batch mode when culture productivity is exceptionally low.
The choice of operation mode by manufacturers is driven by factors such as the type of expres­sion system used, productivity, manufacturing capacity, facility layout, and output.
10.12.1 batch cultuRe
At the start of the process, a batch operation involves a closed vessel system containing all neces­sary medium components, including the required inoculum for fermentation (cell development). No subsequent feeding or addition of supplement components is performed, maintaining a con­stant volume throughout the process. Apart from gases, antifoam, and pH adjusting solutions added at the beginning, the medium composition must meet all nutritional requirements to support cell growth and enhance productivity. The substrate concentration remains at its max­imum within the reactor, while the cell and product concentration start at their lowest. The entire batch is harvested, and the fermentation end time is typically determined by product kinetics (Figure 10.17).
The simplicity of setup and execution led to the widespread application of the batch process, especially during the initial biotechnology phase involving cell mass production or primary product production (e.g., vaccine production using microcarriers). A batch process typically includes phases that dene cell growth: a lag phase, an exponential growth phase, and a stationary phase indicative of harvesting, followed by preparation for a new batch involving cleaning, sterilizing, and lling; Figure 10.17).
The total amount of cell mass- produced in each batch process is calculated per the following equation:
rb = rate of cell mass production per batch cycle and tc = batch cycle time
=
b
=
Equation 10.1